HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wim E Hennink Selected Research

monomethoxypolyethylene glycol (MPEG)

4/2022Utilizing in vitro drug release assays to predict in vivo drug retention in micelles.
8/2015HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth.
1/2015Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles.
7/2011Reprint of "Nanobody--shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting".
4/2011Nanobody-shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting.
10/2010Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wim E Hennink Research Topics

Disease

89Neoplasms (Cancer)
04/2022 - 03/2002
5Hyperthermia
10/2018 - 03/2014
5Inflammation (Inflammations)
09/2018 - 01/2013
4Lung Neoplasms (Lung Cancer)
12/2020 - 12/2010
4Breast Neoplasms (Breast Cancer)
01/2019 - 12/2010
3Communicable Diseases (Infectious Diseases)
01/2021 - 01/2019
3Dehydration (Water Stress)
07/2019 - 10/2004
3Thrombosis (Thrombus)
10/2018 - 03/2014
3Osteoarthritis
10/2018 - 10/2013
3Body Weight (Weight, Body)
03/2018 - 03/2002
3Melanoma (Melanoma, Malignant)
12/2016 - 10/2010
3Carcinoma (Carcinomatosis)
10/2011 - 03/2008
2Milk Hypersensitivity (Milk Allergy)
01/2022 - 01/2018
2Atherosclerosis
01/2022 - 09/2017
2Neoplasm Metastasis (Metastasis)
01/2021 - 07/2012
2Neuroblastoma
01/2021 - 03/2018
2Cholestasis
10/2018 - 01/2016
2Arthritis (Polyarthritis)
01/2014 - 07/2012
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2012 - 09/2008

Drug/Important Bio-Agent (IBA)

34MicellesIBA
01/2022 - 03/2008
24Pharmaceutical PreparationsIBA
01/2021 - 07/2009
15PolymersIBA
06/2020 - 11/2003
13Liposomes (Liposome)IBA
10/2018 - 11/2003
6monomethoxypolyethylene glycol (MPEG)IBA
04/2022 - 10/2010
6Ethylene Glycol (Monoethylene Glycol)IBA
04/2022 - 10/2010
6Proteins (Proteins, Gene)FDA Link
12/2019 - 01/2013
6methacrylamideIBA
10/2018 - 03/2008
5hydroxypropyl methacrylateIBA
04/2022 - 07/2009
5Peptides (Polypeptides)IBA
01/2022 - 01/2017
5HydrogelsIBA
11/2020 - 03/2002
5Small Interfering RNA (siRNA)IBA
05/2020 - 03/2007
5ErbB Receptors (EGF Receptor)IBA
01/2020 - 04/2011
5DNA (Deoxyribonucleic Acid)IBA
11/2016 - 12/2005
5HolmiumIBA
01/2015 - 07/2006
4Cytostatic AgentsIBA
01/2021 - 10/2011
4Lactic Acid (Lactate)FDA LinkGeneric
12/2020 - 10/2010
4temoporfinIBA
12/2020 - 09/2008
4Paclitaxel (Taxol)FDA LinkGeneric
07/2020 - 03/2008
4Phosphotransferases (Kinase)IBA
05/2020 - 04/2012
4VaccinesIBA
12/2019 - 12/2003
4poly(lactide) (polylactic acid)IBA
01/2019 - 07/2006
4LigandsIBA
04/2014 - 12/2010
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2013 - 07/2009
3AntibodiesIBA
11/2022 - 07/2012
3AntigensIBA
01/2022 - 12/2016
3Docetaxel (Taxotere)FDA Link
06/2021 - 03/2008
3CurcuminIBA
01/2021 - 03/2014
3EnzymesIBA
11/2020 - 11/2007
3AlbuminsIBA
07/2020 - 01/2013
3Folic Acid (Vitamin M)FDA LinkGeneric
05/2020 - 04/2014
3Photosensitizing Agents (Photosensitizers)IBA
01/2020 - 12/2014
31-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2020 - 12/2014
3NanogelsIBA
12/2019 - 12/2016
3taxaneIBA
10/2017 - 03/2008
3Drug CarriersIBA
12/2016 - 07/2009
3Dextrans (Dextran)FDA Link
03/2014 - 03/2004
3ProdrugsIBA
03/2014 - 01/2011
3acetyl acetonate (acetylacetonate)IBA
01/2013 - 10/2010
2Lactoglobulins (beta-Lactoglobulin)FDA Link
01/2022 - 01/2018
2Immunoglobulins (Immunoglobulin)IBA
01/2022 - 05/2014
2Immunomodulating AgentsIBA
01/2021 - 01/2019
2arginyl-glycyl-aspartic acidIBA
07/2020 - 02/2014
2TOR Serine-Threonine KinasesIBA
05/2020 - 10/2019
2dactolisibIBA
05/2020 - 10/2019
2Ethanol (Ethyl Alcohol)IBA
01/2020 - 09/2012
2Biological ProductsIBA
01/2020 - 09/2017
2chlorinIBA
01/2020 - 09/2017
2CholesterolIBA
01/2019 - 11/2003
2Biocompatible Materials (Biomaterials)IBA
10/2018 - 09/2011
2Vitamin KFDA Link
10/2018 - 01/2016
2IronIBA
03/2018 - 11/2016
2LipidsIBA
06/2017 - 02/2008
2LuciferasesIBA
06/2017 - 07/2008
2salicylhydroxamic acid (SHAM)IBA
01/2017 - 11/2007
2Silicon Dioxide (Silica)FDA LinkGeneric
12/2016 - 12/2016
2Therapeutic UsesIBA
12/2016 - 06/2007
2Cancer VaccinesIBA
12/2016 - 04/2015
2Hyaluronic Acid (Hyaluronan)IBA
01/2015 - 03/2008
2N-(2-hydroxypropyl)methacrylamideIBA
03/2014 - 12/2010
2GlucocorticoidsIBA
01/2014 - 07/2012
2Insulin-Like PeptidesIBA
10/2013 - 04/2012
2cremophor ELIBA
09/2012 - 03/2008
2Radioisotopes (Radionuclides)IBA
03/2012 - 07/2006
2RhodaminesIBA
07/2011 - 04/2011
2Firefly LuciferasesIBA
04/2011 - 12/2010

Therapy/Procedure

26Therapeutics
01/2021 - 03/2002
8Microspheres (Microsphere)
12/2021 - 07/2006
6Immunotherapy
07/2020 - 03/2014
6Intravenous Administration
10/2018 - 12/2005
5Injections
11/2022 - 10/2010
4Drug Therapy (Chemotherapy)
01/2021 - 12/2010
4Stents
09/2018 - 07/2015
3Transplantation
01/2022 - 01/2020
3Photochemotherapy (Photodynamic Therapy)
01/2020 - 12/2014
2Intravenous Injections
12/2020 - 01/2015
2Palliative Care (Palliative Therapy)
09/2018 - 11/2016
2Radiotherapy
01/2017 - 12/2010
2Phototherapy (Light Therapy)
01/2017 - 12/2016
2Therapeutic Embolization
03/2015 - 01/2013
2Chemoradiotherapy
10/2011 - 12/2010